1.53
전일 마감가:
$1.56
열려 있는:
$1.59
하루 거래량:
256.63K
Relative Volume:
2.59
시가총액:
$26.30M
수익:
$48.43M
순이익/손실:
$-11.04M
주가수익비율:
-2.2836
EPS:
-0.67
순현금흐름:
$-7.00M
1주 성능:
+3.38%
1개월 성능:
+24.39%
6개월 성능:
+8.51%
1년 성능:
-6.39%
Iridex Corp Stock (IRIX) Company Profile
명칭
Iridex Corp
전화
(650) 940-4700
주소
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
IRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
IRIX
Iridex Corp
|
1.53 | 26.82M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-11-03 | 재개 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | ROTH Capital | Buy |
| 2016-01-26 | 개시 | Singular Research | Buy |
| 2007-01-03 | 개시 | First Albany | Buy |
Iridex Corp 주식(IRIX)의 최신 뉴스
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Dizon buys $5k in IRIX stock By Investing.com - Investing.com India
Iridex CFO Dizon buys $5k in IRIX stock - Investing.com
Moving Averages: Is IRIDEX Corporation backed by strong institutional buying2025 Market Sentiment & Weekly High Momentum Picks - baoquankhu1.vn
Iridex CFO Dizon buys $1.8k in IRIX stock By Investing.com - Investing.com India
Iridex CFO Dizon buys $1.8k in IRIX stock - Investing.com
Iridex CFO Dizon buys $7.7k in company stock By Investing.com - Investing.com India
Iridex CFO Dizon buys $7.7k in company stock - Investing.com
Iridex CFO Dizon buys shares worth $6.3k By Investing.com - Investing.com Nigeria
Iridex CFO Dizon buys shares worth $6.3k - Investing.com
Iridex reports 15-17% revenue growth in Q4, achieves positive cash flow - Investing.com
IRIX Projects Significant Revenue Growth with Strategic Initiati - GuruFocus
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 - marketscreener.com
Medical laser maker for glaucoma care turns cash positive after growth push - Stock Titan
Can IRIDEX Corporation stock hit record highs again2025 Market Sentiment & Stock Timing and Entry Methods - ulpravda.ru
IRIDEX Corp: Can This Beaten-Down Ophthalmic Stock Still See The Light? - AD HOC NEWS
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
IRIX SEC FilingsIridex 10-K, 10-Q, 8-K Forms - Stock Titan
Is IRIDEX Corporation stock a top momentum playJuly 2025 Macro Moves & Daily Stock Momentum Reports - Улправда
Published on: 2025-12-19 17:58:41 - Улправда
What margin trends mean for IRIDEX Corporation stockJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - Улправда
[Form 4] IRIDEX CORP Insider Trading Activity - Stock Titan
Why retail investors pile into IRIDEX Corporation stockRisk Management & High Conviction Investment Ideas - Улправда
IRIDEX (IRIX) director William Moore reports 20,000-share stock purchase - Stock Titan
Iridex CFO Dizon buys $2296 in company stock By Investing.com - Investing.com Nigeria
I’ve reviewed the SEC filing and prepared the following news article - Investing.com UK
Dir Moore Buys 30,000 ($28.5K) Of IRIDEX Corp [IRIX] - TradingView — Track All Markets
Iridex CFO Dizon buys $2296 in company stock - Investing.com
IRIDEX Corporation (NASDAQ: IRIX) presents at Sidoti Year-End Virtual Investor Conference - Stock Titan
Iridex study shows MicroPulse laser retreatment effective for glaucoma - Investing.com
Iridex study shows MicroPulse laser retreatment effective for glaucoma By Investing.com - Investing.com Canada
Iridex Corporation Announces Positive Findings on MicroPulse Technology for Glaucoma Retreatment in Independent Study - Quiver Quantitative
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management - The Manila Times
Iridex (IRIX) Reveals Study on Laser Treatments for Glaucoma - GuruFocus
Iridex Corporation Announces Publication of Study on Thermal Dynamics of Laser Treatments for Glaucoma - Quiver Quantitative
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment - marketscreener.com
Iridex (NASDAQ: IRIX) publishes thermal modeling study on MicroPulse vs CW glaucoma lasers - Stock Titan
Iridex (Nasdaq: IRIX) sets Dec. 11 slot at Sidoti virtual investor conference - Stock Titan
Is IRIDEX Corporation stock vulnerable to regulatory risksJuly 2025 Action & AI Enhanced Trading Signals - Newser
Iridex (IRIX) Stock Analysis Report | Financials & Insights - Benzinga
Iridex CFO Dizon buys $5529 in company stock By Investing.com - Investing.com Australia
Iridex CFO Dizon buys $5529 in company stock - Investing.com India
Iridex CFO Dizon buys $960 in company stock By Investing.com - Investing.com South Africa
Iridex Corp (IRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):